As part of its work to deliver on its 2020 strategic plan, and the opportunities that lay ahead, the Canadian Medical Association (CMA) is adapting its governance structure.
The CMA Board of Directors is expanding the CMA’s Chief Executive Officer (CEO) role to also include responsibility as CEO for the CMA Group of Companies. This will see the CMA’s current CEO, Tim Smith, assume CEO responsibilities for CMAH 2018 and CMA Investco Inc. Mr. Smith will also provide strategic oversight for Joule, working with its CEO and Board members.
This approach will help maximize the unique strengths of each subsidiary and provide more opportunities to align their work to deliver meaningful impact.
At its May 1 meeting, the CMA Board appointed the new board members for CMAH 2018 and the CMA Foundation. They will begin their term in August 2019. They are:
- Dr. Chris Carruthers, Board Chair
- Dr. Celina White
- Dr. Guruswamy Sridhar
- Mr. Iain Scott
- Ms. Martha Tory
- Dr. David Naylor
- Mr. Tim Smith
The CMA Board also appointed a non-physician member to sit on its board. Ms. Janet Ecker will join the Board at the close of the 2019 AGM and Health Summit on August 13. In addition, the CMA Foundation Board will appoint a new member with particular expertise in philanthropy in August 2019.
Under this new corporate structure, the CMA will be well-positioned to continue its work supporting physicians and advocating for better health.
About the CMA corporate structure
CMAH 2018 oversees the CMA subsidiaries and promotes alignment with the strategy set forth by the CMA Board of Directors.
Joule helps physicians be their best by supporting physician-led innovation, providing learning opportunities for physicians, and by offering access to leading evidence-based clinical products and research.
The CMA Foundation provides impactful, charitable giving to registered Canadian charities to further excellence in health care.
CMA Investco Inc. is responsible for monitoring and managing the CMA’s assets.